Evommune, Inc.
NYSEEVMN cost to borrow doubles to 3.67%, up 106% in one week amid analyst downgrades and elevated short interest at 16.6% of float.
Short interest % of float, cost to borrow, utilization, and put/call ratio for EVMN are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 1 Jul 2026
No long-form analysis yet for EVMN. Pulse alerts and the live data picture are available on ORTEX.
Open EVMN on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EVMN — free to start on ORTEX.
Sign up for free →Open EVMN on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live EVMN data →